NEW YORK, Feb. 13, 2018 -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) between March 15, 2017 and December 27, 2017, both dates inclusive (“Class Period”) of the important March 5, 2018 lead plaintiff deadline in the first class action commenced by the Rosen Law Firm. The lawsuit seeks to recover damages for Ekso investors under the federal securities laws.
To join the Ekso class action, go to http://www.rosenlegal.com/cases-1262.html or call Phillip Kim, Esq. or Daniel Sadeh, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) there was a material weakness in Ekso’s internal control over financial reporting and Ekso’s disclosure controls and procedures were not effective; and (2) as a result, Defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 5, 2018. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://www.rosenlegal.com/cases-1262.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim or Daniel Sadeh of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected] or [email protected].
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Since 2014, Rosen Law Firm has been ranked #2 in the nation by Institutional Shareholder Services for the number of securities class action settlements annually obtained for investors. Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
Daniel Sadeh, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 34th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
[email protected]
[email protected]
www.rosenlegal.com


Vale Reports $3.8 Billion Q4 Net Loss Amid Nickel Asset Impairment and Samarco Provisions
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks
Westpac (ASX: WBC) Q1 Profit Rises 6% as Lending Growth and Treasury Income Strengthen Earnings
GE Aerospace Expands Singapore Engine Repair Hub with Automation and AI to Tackle Aviation Bottlenecks
Russia Moves to Fully Block WhatsApp as Kremlin Pushes State-Backed MAX App
More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes
SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms
Gates Foundation Denies Financial Ties to Jeffrey Epstein Following DOJ Email Release
How Marco Pharma International Preserves German Homeopathic Traditions in America
Converse Cuts Corporate Jobs as Nike Restructures to Revive Sales Growth
Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
Michael Kors Marks 45 Years at New York Fashion Week with Fall/Winter Collection Showcase
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act
Instagram CEO Defends Platform in Youth Mental Health Lawsuit Over Social Media Addiction Claims
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan 



